Tirzepatide currently being a twin GLP-1 and GIP agonist, it is actually proposed that the GIP part of dual agonism might be to blame for the additional benefit, offered the opportunity good thing about GIP receptor agonism on peripheral insulin sensitization. Consequently, tirzepatide was more practical than dulaglutide in decreasing fasting diet